Anxiety Schizophrenia

A game that claims to reduce symptoms of schizophrenia will be put before the FDA – but would their approval be a boon or a burden for the industry?

( JAMA and Archives Journals ) A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these

NEW YORK (Reuters Health) - Newer antipsychotics are often prescribed for conditions they aren't approved to treat -- with questionable benefit, according to new research.

A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these medications are effective for o

A review of previous studies suggests that even though atypical antipsychotic medications are commonly used for off-label conditions such as behavioral symptoms of dementia, anxiety, and obsessive-compulsive disorder, these medications are effective for o